In Oslo, Norway
"Pharmasum is gearing up to enter clinical studies in Down syndrome.
We are trying to dramatically improve the lives of individuals with Down syndrome, by improving cognition and possibly slowing down...
4th – 7th June 2018
13th - 14th November 2017
In Basel, Switzerland.
At the NY Academy of Sciences, New York, USA.
Pharmasum Therapeutics AS (“Pharmasum” or the “Company”), a neuroscience drug development company, is pleased to announce the successful completion of a share issue of NOK 8.3 million from...
Tromsø, Norway, January 30, 2015 – Pharmasum Therapeutics AS (“Pharmasum” or the “Company”), a neuroscience drug development company, is pleased to announce the award of a grant...
Please click here to view PDF
Please click here to view PDF
Please click here to view...